Andrew Valiere

Andrew Valiere has a diverse work experience in the field of research and development. Andrew worked as a Senior Research Associate at Treeline Biosciences from February 2022. Prior to this, they served as a Senior Scientist I at GNF from December 2016 to February 2022. During their time at GNF, they focused on regenerative medicine and medicinal chemistry, where they obtained patents and gained experience in phenotype-driven drug discovery.

Before joining GNF, Andrew worked as an Associate Scientist II at AviSyn Pharma on contract at Dart Neuroscience from May 2016 to November 2016, continuing their previous employment. Additionally, they served as a Research Associate I at Dart NeuroScience LLC from June 2015 to May 2016. In this role, they collaborated with the process chemistry group and co-authored a publication on selective N-alkylations.

Earlier in their career, Andrew worked as an Associate Chemist at Inception Sciences, Inc. from May 2014 to June 2015, where they focused on target-driven medicinal chemistry. Andrew also gained experience as a Research Operations Intern at GNF from July 2013 to May 2014.

Overall, Andrew Valiere's work experience demonstrates their strong background in medicinal chemistry, research, and development, with a focus on regenerative medicine and drug discovery.

Andrew Valiere attended Cuyamaca College from 2008 to 2010, where they obtained an Associate of Science degree in Science and Mathematics. Andrew then pursued further education at San Diego State University from 2010 to 2014, earning a Bachelor of Science degree in Chemistry.